First-line modified-FOLFIRI plus bevacizumab or panitumumab in older patients with metastatic colorectal cancer: Results of two parallel phase II trials from Hellenic Oncology Research Group

IF 2.9 3区医学 Q3 GERIATRICS & GERONTOLOGY

Journal of geriatric oncology Pub Date : 2026-03-01 Epub Date: 2026-03-13 DOI:10.1016/j.jgo.2026.102873

A. Karampeazis, L. Vamvakas, A. Kotsakis, N. Vardakis, E. Kontopodis, J. Souglakos, D. Chatzidaki, V. Georgoulias, Hellenic Oncology Research Group

引用次数: 0

查看原文本刊更多论文

一线改良folfiri联合贝伐单抗或帕尼单抗治疗老年转移性结直肠癌：来自希腊肿瘤研究小组的两项平行II期试验的结果

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of geriatric oncology ONCOLOGY-GERIATRICS & GERONTOLOGY

CiteScore

5.30

自引率

10.00%

发文量

379

审稿时长

80 days

期刊介绍： The Journal of Geriatric Oncology is an international, multidisciplinary journal which is focused on advancing research in the treatment and survivorship issues of older adults with cancer, as well as literature relevant to education and policy development in geriatric oncology. The journal welcomes the submission of manuscripts in the following categories: • Original research articles • Review articles • Clinical trials • Education and training articles • Short communications • Perspectives • Meeting reports • Letters to the Editor.